Desmoplastic small round cell tumors: Multimodality treatment and new risk factors

To evaluate optimal therapy and potential risk factors.

[1]  S. Cohen-Gogo,et al.  Systemic therapy in pediatric-type soft-tissue sarcoma. , 2020, Current oncology.

[2]  N. André,et al.  Metronomic Chemotherapy for Children in Low- and Middle-Income Countries: Survey of Current Practices and Opinions of Pediatric Oncologists , 2019, Journal of global oncology.

[3]  Michael W. Bishop,et al.  Desmoplastic small round cell tumor: A nationwide study of a rare sarcoma , 2018, Journal of surgical oncology.

[4]  S. Bielack,et al.  Importance of whole-body imaging with complete coverage of hands and feet in alveolar rhabdomyosarcoma staging , 2018, Pediatric Radiology.

[5]  C. Warneke,et al.  Clinical Activity of Pazopanib in Patients with Advanced Desmoplastic Small Round Cell Tumor , 2017, The oncologist.

[6]  D. McMillan,et al.  The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis , 2017, Scientific Reports.

[7]  M. Toulmonde,et al.  Clinical activity of eribulin in advanced desmoplastic small round-cell tumor. , 2017, Anti-cancer drugs.

[8]  B. Laird,et al.  The role of the systemic inflammatory response in predicting outcomes in patients with advanced inoperable cancer: Systematic review and meta-analysis. , 2017, Critical reviews in oncology/hematology.

[9]  A. Nayak,et al.  Elevated Preoperative Neutrophil–Lymphocyte Ratio is Predictive of a Poorer Prognosis for Pediatric Patients with Solid Tumors , 2017, Annals of Surgical Oncology.

[10]  A. Santoro,et al.  Imatinib mesylate in desmoplastic small round cell tumors. , 2017, Future oncology.

[11]  J. Blay,et al.  Antiangiogenic effects in patients with progressive desmoplastic small round cell tumor: data from the French national registry dedicated to the use of off-labeled targeted therapy in sarcoma (OUTC’s) , 2017, Clinical Sarcoma Research.

[12]  U. Dirksen,et al.  Results for patients with sarcoma not otherwise specified and other diagnoses than Ewing sarcoma treated according to the Euro‐EWING 99 trial , 2017, Pediatric blood & cancer.

[13]  J. Blay,et al.  Abdominal desmoplastic small round cell tumor without extraperitoneal metastases: Is there a benefit for HIPEC after macroscopically complete cytoreductive surgery? , 2017, PloS one.

[14]  Dominique Latinne,et al.  What is the normal value of the neutrophil-to-lymphocyte ratio? , 2017, BMC Research Notes.

[15]  M. LaQuaglia,et al.  Management of desmoplastic small round cell tumor. , 2016, Seminars in pediatric surgery.

[16]  Kohji Okamoto,et al.  Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis , 2016, Thrombosis Journal.

[17]  S. Bielack,et al.  Synovial Sarcoma Recurrence in Children and Young Adults , 2016, Annals of Surgical Oncology.

[18]  A. Fukao,et al.  Desmoplastic Small Round Cell Tumor of the Pleura Successfully Treated with a Lower Dose of Pazopanib. , 2016, Internal medicine.

[19]  D. Orbach,et al.  Role of Adjuvant Radiation Therapy After Surgery for Abdominal Desmoplastic Small Round Cell Tumors. , 2016, International journal of radiation oncology, biology, physics.

[20]  M. McAleer,et al.  Survival and toxicity following sequential multimodality treatment including whole abdominopelvic radiotherapy for patients with desmoplastic small round cell tumor. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  S. Bielack,et al.  Primary Metastatic Synovial Sarcoma: Experience of the CWS Study Group , 2016, Pediatric blood & cancer.

[22]  A. Hayes-Jordan.  Cytoreductive Surgery Followed by Hyperthermic Intraperitoneal Chemotherapy in DSRCT: Progress and Pitfalls , 2015, Current Oncology Reports.

[23]  M. LaQuaglia,et al.  Myeloablative Chemotherapy with Autologous Stem Cell Transplant for Desmoplastic Small Round Cell Tumor , 2015, Sarcoma.

[24]  P. Terrier,et al.  Abdominal Desmoplastic Small Round Cell Tumor: Multimodal Treatment Combining Chemotherapy, Surgery, and Radiotherapy is the Best Option , 2015, Annals of Surgical Oncology.

[25]  M. McAleer,et al.  Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Children, Adolescents, and Young Adults: The First 50 Cases , 2015, Annals of Surgical Oncology.

[26]  S. Bielack,et al.  Tumour volume reduction after neoadjuvant chemotherapy impacts outcome in localised embryonal rhabdomyosarcoma , 2015, Pediatric blood & cancer.

[27]  F. Langer,et al.  Pathophysiology of Trousseau’s syndrome , 2018, Phlebologie.

[28]  P. Garcia-Filion,et al.  Incidence and Outcomes of Desmoplastic Small Round Cell Tumor: Results from the Surveillance, Epidemiology, and End Results Database , 2014, Journal of cancer epidemiology.

[29]  S. Clarke,et al.  Cancer-related inflammation and treatment effectiveness. , 2014, The Lancet. Oncology.

[30]  V. Lorusso,et al.  Third-line trabectedin for a metastatic desmoplastic small round cell tumour treated with multimodal therapy. , 2014, Anticancer research.

[31]  P. Dileo,et al.  Trabectedin for desmoplastic small round cell tumours: a possible treatment option? , 2014, Clinical Sarcoma Research.

[32]  R. A. de Araújo,et al.  Desmoplastic Small Round Cell Tumor: Report of 2 Cases Treated with Chemotherapy Alone or in Combination with Bevacizumab , 2014, Case Reports in Oncology.

[33]  H. Earl,et al.  Desmoplastic small round cell tumour: characteristics and prognostic factors of 41 patients and review of the literature , 2013, Clinical Sarcoma Research.

[34]  S. Braekkan,et al.  Epidemiology of cancer-associated venous thrombosis. , 2013, Blood.

[35]  I. Leuschner,et al.  Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study. , 2013, The Lancet. Oncology.

[36]  T. Nguyen,et al.  Evaluation of the International Society on Thrombosis and Haemostasis and institutional diagnostic criteria of disseminated intravascular coagulation in pediatric patients. , 2013, American journal of clinical pathology.

[37]  A. Walker,et al.  Incidence of venous thromboembolism in patients with cancer - a cohort study using linked United Kingdom databases. , 2013, European journal of cancer.

[38]  B. Bui,et al.  Clinical activity of sunitinib in patients with advanced desmoplastic round cell tumor: a case series , 2013, Targeted Oncology.

[39]  E. Bayever,et al.  A phase I trial and pharmacokinetic study of a 24‐hour infusion of trabectedin (Yondelis®, ET‐743) in children and adolescents with relapsed or refractory solid tumors , 2012, Pediatric blood & cancer.

[40]  D. Dunkler,et al.  Tumor grade is associated with venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  M. Provencio,et al.  Activity of trabectidin in desmoplastic small round cell tumor , 2011, Medical oncology.

[42]  L. Thabane,et al.  Epidemiology and clinical risk factors predisposing to thromboembolism in children with cancer , 2008, Pediatric blood & cancer.

[43]  T. Klingebiel,et al.  Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: Report of the HD CWS‐96 trial , 2008, Pediatric blood & cancer.

[44]  F. Grosso,et al.  Response to vinorelbine and low‐dose cyclophosphamide chemotherapy in two patients with desmoplastic small round cell tumor , 2007, Pediatric blood & cancer.

[45]  A. Varki.  Trousseau's syndrome: multiple definitions and multiple mechanisms. , 2007, Blood.

[46]  Anthony K. C. Chan,et al.  Thromboembolism in children with sarcoma , 2007, Pediatric blood & cancer.

[47]  L. Helman,et al.  Thromboembolic events in children and young adults with pediatric sarcoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  B. Meister,et al.  Treatment for soft tissue sarcoma in childhood and adolescence , 2005, Wiener klinische Wochenschrift.

[49]  A. Bertuzzi,et al.  Prospective study of high-dose chemotherapy and autologous peripheral stem cell transplantation in adult patients with advanced desmoplastic small round-cell tumour , 2003, British Journal of Cancer.

[50]  M. Alloisio,et al.  High-dose chemotherapy in poor-prognosis adult small round-cell tumors: clinical and molecular results from a prospective study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  F B Taylor,et al.  Towards Definition, Clinical and Laboratory Criteria, and a Scoring System for Disseminated Intravascular Coagulation , 2001, Thrombosis and Haemostasis.

[52]  P. Rosoff,et al.  Successful clinical response to irinotecan in desmoplastic round blue cell tumor. , 1999, Medical and pediatric oncology.

[53]  W. Gerald,et al.  Desmoplastic small round cell tumors: Prognostic indicators and results of surgical management , 1998, Annals of Surgical Oncology.

[54]  W. Gerald,et al.  Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[55]  S. Culine,et al.  Desmoplastic small round cell tumors: results of a four‐drug chemotherapy regimen in five adult patients , 1996, Cancer.

[56]  W. Gerald,et al.  Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor. , 1994, Cancer research.

[57]  H. Jürgens,et al.  Treatment of soft tissue sarcoma in childhood and adolescence: A report of the german cooperative soft tissue sarcoma study , 1992, Cancer.

[58]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[59]  P. Terrier,et al.  Trabectedin in advanced desmoplastic round cell tumors: a retrospective single-center series , 2017, Anti-cancer drugs.

[60]  J. Ludwig,et al.  Complete Cytoreduction and HIPEC Improves Survival in Desmoplastic Small Round Cell Tumor , 2013, Annals of Surgical Oncology.

[61]  K. Goodman,et al.  Clinical Investigation : Sarcoma Reduced Toxicity With Intensity Modulated Radiation Therapy ( IMRT ) for Desmoplastic Small Round Cell Tumor ( DSRCT ) : An Update on the Whole Abdominopelvic Radiation Therapy ( WAP-RT ) Experience , 2022 .

[62]  S. Bielack,et al.  Report of the CWS 2002P Study : Treatment Results for Soft Tissue Sarcomas (STS) in Childhood and Adolescence , 2013 .

[63]  C. Bokemeyer,et al.  Zusammenspiel von Tumorwachstum und Hämostaseaktivierung – Bedeutung von Tissue-Faktor für Tumorbiologie und tumorassoziierte Thrombose , 2012 .

[64]  C. Bokemeyer,et al.  Crosstalk between cancer and haemostasis , 2012, Hämostaseologie.

[65]  S. Wolden,et al.  Results of multimodal treatment for desmoplastic small round cell tumors. , 2005, Journal of pediatric surgery.

[66]  I. Kiricuta.  TNM system. , 1993, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[67]  W. Gerald,et al.  Case 2. Desmoplastic small cell tumor with divergent differentiation. , 1989, Pediatric pathology.